Results 181 to 190 of about 12,992 (201)

Eculizumab

Reactions Weekly, 2017
  +4 more sources

Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease

Journal of Infection, 2020
Lucy McNamara, Page Crew
exaly  

Unusual Neisseria species as a cause of infection in patients taking eculizumab

Journal of Infection, 2019
Lucy McNamara, Page Crew
exaly  

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Blood, 2008
Peter Hillmen, Robert Brodsky, Antonio Maria Risitano   +2 more
exaly  

A randomized, double‐blind, single‐dose, three‐arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris®) in healthy male subjects

European Journal of Haematology, 2020
Vladimir Hanes, David Chien
exaly  

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome

CKJ: Clinical Kidney Journal, 2017
Karine Hadaya, Nils Heyne, Manuel Macià   +2 more
exaly  

Eculizumab

Reactions Weekly, 2012
openaire   +2 more sources

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy

American Journal of Kidney Diseases, 2018
Fadi Fakhouri, Pourcine Franck, Stéphane Decramer   +2 more
exaly  

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation, 2016
Tsuyoshi Fukuda, Sonata Jodele, Jens Goebel   +2 more
exaly  

Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy

Biology of Blood and Marrow Transplantation, 2014
Lily Lu, Fred Pluthero, Tsuyoshi Fukuda   +2 more
exaly